Enanta Pharmaceuticals, Inc. Announces The Appointment Of Nathaniel S. Gardiner, J.D. As Senior Vice President And General Counsel
5/12/2014 7:10:44 AM
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced the appointment of Nathaniel S. Gardiner, J.D. as Senior Vice President and General Counsel. Mr. Gardiner has over 25 years of experience as outside general counsel advising private and public biotechnology companies.
Help employers find you! Check out all the jobs and post your resume.
comments powered by